IVA

3.1408.99%
HC

Heinz Christoph Maeusli

Independent Director

Mr. Heinz Christoph Maeusli is Independent Non-executive Director of newcleo plc. Mr. Maeusli has been Independent Director at Inventiva S.A. since May 27, 2019. He was Chief Financial Officer of Advanced Accelerator Applications (AAA) from 2003 to 2018, Mr. Maeusli has been instrumental in growing this company into a global leader in its sector. Since November 2019, Mr. Maeusli has served on the board of directors of Progenics Pharmaceuticals. As such, he has driven the listing of AAA on the Nasdaq stock exchange in November 2015 and contributed to AAA’s sale to Novartis in January 2018. Throughout his career, he has developed an expertise in the operational, organizational, financial and cultural complexities of growing and integrating international companies. Mr. Maeusli holds an MBA from Columbia University, New York, USA in 1995 and a licentiate degree in 1988 from the University of St. Gallen.

Positions